BEVALTIA

Welcome to the Brand page for “BEVALTIA”, which is offered here for Pharmaceutical preparations for human use; biologic preparations for medical and therapeutic purposes; pharmaceutical preparations to treat inflammatory diseases and disorders and diseases and disorders of the immune system; pharmaceutical preparations to treat dermatomyositis, systemic lupus erythematosus (sle), hidradenitis suppurativa, scleroderma, sarcoidosis, juvenile dermatomyositis, and non-infectious uveitis;.

Its status is currently believed to be active. Its class is unavailable. “BEVALTIA” is believed to be currently owned by “Roivant Sciences GmbH”.